Global Syndromic Diagnostic Test Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR022403016

Publication Date:

February 26, 2024

Pages:

134

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Software [2]

IT Services [3]

Computing & Electronics [4]

Description:

The global Syndromic Diagnostic Test market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
This report studies the global Syndromic Diagnostic Test demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Syndromic Diagnostic Test, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Syndromic Diagnostic Test that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Syndromic Diagnostic Test total market, 2019-2030, (USD Million)
Global Syndromic Diagnostic Test total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Syndromic Diagnostic Test total market, key domestic companies and share, (USD Million)
Global Syndromic Diagnostic Test revenue by player and market share 2019-2024, (USD Million)
Global Syndromic Diagnostic Test total market by Type, CAGR, 2019-2030, (USD Million)
Global Syndromic Diagnostic Test total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Syndromic Diagnostic Test market based on the following parameters 鈥� company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin and 产颈辞惭茅谤颈别耻虫, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Syndromic Diagnostic Test market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Syndromic Diagnostic Test Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Syndromic Diagnostic Test Market, Segmentation by Type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Global Syndromic Diagnostic Test Market, Segmentation by Application
Hospital
Laboratory
Research Institution
Others
Companies Profiled:
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
产颈辞惭茅谤颈别耻虫
QIAGEN
Key Questions Answered
1. How big is the global Syndromic Diagnostic Test market?
2. What is the demand of the global Syndromic Diagnostic Test market?
3. What is the year over year growth of the global Syndromic Diagnostic Test market?
4. What is the total value of the global Syndromic Diagnostic Test market?
5. Who are the major players in the global Syndromic Diagnostic Test market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 Syndromic Diagnostic Test Introduction
1.2 World Syndromic Diagnostic Test Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Syndromic Diagnostic Test Total Market by Region (by Headquarter Location)
1.3.1 World Syndromic Diagnostic Test Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Syndromic Diagnostic Test Market Size (2019-2030)
1.3.3 China Syndromic Diagnostic Test Market Size (2019-2030)
1.3.4 Europe Syndromic Diagnostic Test Market Size (2019-2030)
1.3.5 Japan Syndromic Diagnostic Test Market Size (2019-2030)
1.3.6 South Korea Syndromic Diagnostic Test Market Size (2019-2030)
1.3.7 ASEAN Syndromic Diagnostic Test Market Size (2019-2030)
1.3.8 India Syndromic Diagnostic Test Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Syndromic Diagnostic Test Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Syndromic Diagnostic Test Major Market Trends
2 Demand Summary
2.1 World Syndromic Diagnostic Test Consumption Value (2019-2030)
2.2 World Syndromic Diagnostic Test Consumption Value by Region
2.2.1 World Syndromic Diagnostic Test Consumption Value by Region (2019-2024)
2.2.2 World Syndromic Diagnostic Test Consumption Value Forecast by Region (2025-2030)
2.3 United States Syndromic Diagnostic Test Consumption Value (2019-2030)
2.4 China Syndromic Diagnostic Test Consumption Value (2019-2030)
2.5 Europe Syndromic Diagnostic Test Consumption Value (2019-2030)
2.6 Japan Syndromic Diagnostic Test Consumption Value (2019-2030)
2.7 South Korea Syndromic Diagnostic Test Consumption Value (2019-2030)
2.8 ASEAN Syndromic Diagnostic Test Consumption Value (2019-2030)
2.9 India Syndromic Diagnostic Test Consumption Value (2019-2030)
3 World Syndromic Diagnostic Test Companies Competitive Analysis
3.1 World Syndromic Diagnostic Test Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Syndromic Diagnostic Test Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Syndromic Diagnostic Test in 2023
3.2.3 Global Concentration Ratios (CR8) for Syndromic Diagnostic Test in 2023
3.3 Syndromic Diagnostic Test Company Evaluation Quadrant
3.4 Syndromic Diagnostic Test Market: Overall Company Footprint Analysis
3.4.1 Syndromic Diagnostic Test Market: Region Footprint
3.4.2 Syndromic Diagnostic Test Market: Company Product Type Footprint
3.4.3 Syndromic Diagnostic Test Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: Syndromic Diagnostic Test Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Syndromic Diagnostic Test Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Syndromic Diagnostic Test Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Syndromic Diagnostic Test Consumption Value Comparison
4.2.1 United States VS China: Syndromic Diagnostic Test Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Syndromic Diagnostic Test Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Syndromic Diagnostic Test Companies and Market Share, 2019-2024
4.3.1 United States Based Syndromic Diagnostic Test Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Syndromic Diagnostic Test Revenue, (2019-2024)
4.4 China Based Companies Syndromic Diagnostic Test Revenue and Market Share, 2019-2024
4.4.1 China Based Syndromic Diagnostic Test Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Syndromic Diagnostic Test Revenue, (2019-2024)
4.5 Rest of World Based Syndromic Diagnostic Test Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Syndromic Diagnostic Test Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Syndromic Diagnostic Test Revenue, (2019-2024)
5 Market Analysis by Type
5.1 World Syndromic Diagnostic Test Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Nucleic Acid Extraction Test
5.2.2 Polymerase Chain Reaction (PCR) Test
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Syndromic Diagnostic Test Market Size by Type (2019-2024)
5.3.2 World Syndromic Diagnostic Test Market Size by Type (2025-2030)
5.3.3 World Syndromic Diagnostic Test Market Size Market Share by Type (2019-2030)
6 Market Analysis by Application
6.1 World Syndromic Diagnostic Test Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Laboratory
6.2.3 Research Institution
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Syndromic Diagnostic Test Market Size by Application (2019-2024)
6.3.2 World Syndromic Diagnostic Test Market Size by Application (2025-2030)
6.3.3 World Syndromic Diagnostic Test Market Size by Application (2019-2030)
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott Syndromic Diagnostic Test Product and Services
7.1.4 Abbott Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 Hologic
7.2.1 Hologic Details
7.2.2 Hologic Major Business
7.2.3 Hologic Syndromic Diagnostic Test Product and Services
7.2.4 Hologic Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Hologic Recent Developments/Updates
7.2.6 Hologic Competitive Strengths & Weaknesses
7.3 Applied BioCode
7.3.1 Applied BioCode Details
7.3.2 Applied BioCode Major Business
7.3.3 Applied BioCode Syndromic Diagnostic Test Product and Services
7.3.4 Applied BioCode Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Applied BioCode Recent Developments/Updates
7.3.6 Applied BioCode Competitive Strengths & Weaknesses
7.4 Danaher
7.4.1 Danaher Details
7.4.2 Danaher Major Business
7.4.3 Danaher Syndromic Diagnostic Test Product and Services
7.4.4 Danaher Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 Danaher Recent Developments/Updates
7.4.6 Danaher Competitive Strengths & Weaknesses
7.5 Diagenode
7.5.1 Diagenode Details
7.5.2 Diagenode Major Business
7.5.3 Diagenode Syndromic Diagnostic Test Product and Services
7.5.4 Diagenode Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Diagenode Recent Developments/Updates
7.5.6 Diagenode Competitive Strengths & Weaknesses
7.6 Curetis
7.6.1 Curetis Details
7.6.2 Curetis Major Business
7.6.3 Curetis Syndromic Diagnostic Test Product and Services
7.6.4 Curetis Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 Curetis Recent Developments/Updates
7.6.6 Curetis Competitive Strengths & Weaknesses
7.7 Bio-Rad
7.7.1 Bio-Rad Details
7.7.2 Bio-Rad Major Business
7.7.3 Bio-Rad Syndromic Diagnostic Test Product and Services
7.7.4 Bio-Rad Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 Bio-Rad Recent Developments/Updates
7.7.6 Bio-Rad Competitive Strengths & Weaknesses
7.8 DiaSorin
7.8.1 DiaSorin Details
7.8.2 DiaSorin Major Business
7.8.3 DiaSorin Syndromic Diagnostic Test Product and Services
7.8.4 DiaSorin Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 DiaSorin Recent Developments/Updates
7.8.6 DiaSorin Competitive Strengths & Weaknesses
7.9 产颈辞惭茅谤颈别耻虫
7.9.1 产颈辞惭茅谤颈别耻虫 Details
7.9.2 产颈辞惭茅谤颈别耻虫 Major Business
7.9.3 产颈辞惭茅谤颈别耻虫 Syndromic Diagnostic Test Product and Services
7.9.4 产颈辞惭茅谤颈别耻虫 Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 产颈辞惭茅谤颈别耻虫 Recent Developments/Updates
7.9.6 产颈辞惭茅谤颈别耻虫 Competitive Strengths & Weaknesses
7.10 QIAGEN
7.10.1 QIAGEN Details
7.10.2 QIAGEN Major Business
7.10.3 QIAGEN Syndromic Diagnostic Test Product and Services
7.10.4 QIAGEN Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 QIAGEN Recent Developments/Updates
7.10.6 QIAGEN Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Syndromic Diagnostic Test Industry Chain
8.2 Syndromic Diagnostic Test Upstream Analysis
8.3 Syndromic Diagnostic Test Midstream Analysis
8.4 Syndromic Diagnostic Test Downstream Analysis
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
产颈辞惭茅谤颈别耻虫
QIAGEN

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂